Genentech

By Heather Mack July 11, 2017
With all the recent technological approaches to clinical trials as of late, it’s clear that the notoriously long, expensive and often inefficient traditional process could use an update. From AI-powered matching platforms to increasingly sophisticated software to streamline data collection during trials, the space is getting busier. Palo Alto-based monARC Bionetworks is one of the latest to make...
By Heather Mack March 14, 2017
For people living with the autoimmune disease multiple sclerosis (MS), there can be many impediments to traveling to the neurologist’s office for regular visits, including personal mobility limitations, pain, or vision impairments. And those are just the physical challenges of MS. For those who live in medically underserved areas, the barriers become even greater, as University of California,...
By Heather Mack August 12, 2016
San Francisco-based Castlight Health, which offers a personalized health shopping platform aimed at equipping employees with transparency on both pricing and quality, added some big names to its subscription service and saw increase in both revenue and cash in the second quarter of 2016. Additionally, the company is focusing its sales model by leveraging the data sets provided by its health...
By Aditi Pai October 15, 2015
Mail-order personal genetics service and research company 23andMe has completed a $115 million in a round led by Fidelity Management and Research Company with participation from  Casdin Capital, WuXi Healthcare Ventures, and Xfund, as well as existing investors Illumina, New Enterprise Associates, MPM Capital, and Google Ventures. Part of this funding round was disclosed earlier this year when...
By Jonah Comstock October 8, 2015
Propeller Health is working with Boehringer Ingelheim. Pharma's investment in the digital health space is getting more and more real and substantive as companies move beyond the pilot stage and start to launch real digital health interventions, from Teva buying up smart inhaler company Gecko to Otsuka gearing up to launch a commercial drug integrated with a Proteus sensor. But digital...
By Jonah Comstock July 6, 2015
According to an SEC filing, mail-order personal genome service and research company 23andMe has raised $79 million, in a round the company hopes will top out at $150 million. The investors are undisclosed and 23andMe declined to comment while the round was ongoing. This is the company's largest single funding raise to date. It brings its total funding to $190 million a $1.4 million research...
By Jonah Comstock June 8, 2015
David Ebersman Lyra Health, a startup that launched last week, will focus on addressing the gaps in the healthcare system surrounding behavioral health conditions like anxiety and depression. David Ebersman, former CFO of Facebook and Genentech, will helm the new company, which already has seed funding from Ebersman and venture capital firm Venrock. Ebersman's co-founder, Chief Medical Officer...
By Jonah Comstock May 26, 2015
Cambridge-based online patient community business PatientsLikeMe is teaming up with Boston-area health system Partners HealthCare to provide information and insights from PLM's platform to Partners' patients. “We’re excited to work with such an esteemed health system to help patients and their care teams have a more complete understanding of patients’ whole health experience, and to support...
By Jonah Comstock September 23, 2014
Roche subsidiary Genentech is no stranger to online patient communities -- the pharma company signed a five-year data access deal with online patient community company PatientsLikeMe in April. At the Health 2.0 conference in Santa Clara this week, Genentech product development leader Joling Mew spoke about the ways that Genentech has worked with PatientsLikeMe, and other online patient...
By Jonah Comstock April 10, 2014
Boston-based PatientsLikeMe, a hub for crowd-sourced patient data and an open research platform, has announced its most wide-reaching pharma partnership yet, a five-year agreement to share data with Genentech, a division of Roche. "They are a forward-looking company in the health IT space, and ... I think they're really looking at new forms of evidence and how that can improve their business and...
dopingman.com.ua

www.medicaments-24.com

rtic hopper